Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027

Q: How big is the Influenza Diagnostics market?

Ans. The global Influenza Diagnostics market size is projected to reach US$ 3374.9 million by 2027, from US$ 2195.6 million in 2020, at a CAGR of 6.3% during 2021-2027.

Q: Who are the major producers in the Influenza diagnostics industry?

Ans. The major producers in this industry are BD, Abbott (Include Alere) and Roche, whose combined revenue ratio in 2019 is 50.61%.

Q: Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

Code: QYRE-Auto-13Z613

Report

June 2021

105 Pages

QYResearch

Region: Global, North America, China, Europe, Japan, France, Germany, South Korea, Italy, India, Taiwan, Australia, Thailand, Saudi Arabia, Turkey, Malaysia, Philippines, Indonesia

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott (Include Alere)

Influenza Diagnostics Market

The global Influenza Diagnostics market size is projected to reach USD 3374.9 Million by 2027, from USD 2195.6 Million in 2020, at a CAGR of 6.3% during 2021-2027. Key drivers of the influenza diagnostics market include growing prevalence of influenza and increasing research for diagnostic technologies. Further growing awareness and the need for early detection of the disease is also fuelling the growth of the influenza diagnostics market during the forecast period. Moreover, the emergence of covid 19 has upped the use of influenza diagnostic kits due to similarities shared between the two diseases and easy approvals is leading companies to create presence in global markets ultimately surging the market growth.

Influenza Diagnostics Market

Trends Influencing the Global Influenza Diagnostics Market

Growing prevalence of influenza and increasing research for diagnostic technologies

Influenza is a leading cause for morbidity and mortality in the general human population. Several initiatives and research funding are being done to develop diagnostic technologies for tackling the influenza virus. These new tools based on genomic and proteomic technologies help detect the viruses, deliver better surveillance and diagnose the disease quickly. Scientists are able to focus efficiently on areas such as vaccine development and other therapeutic strategies. Thus growing prevalence of influenza and rapid developments in diagnostic technologies is expected to fuel the growth of the influenza diagnostics market during the forecast period.

Growing awareness and the need for early detection of disease

There is a growing awareness regarding the virus. Organizations are keen on promoting early detection and diagnosis of the disease for eliminating influenza related death. RIDT( Rapid Influenza Diagnostic Testing) is cost efficient and has the ability to provide test results under 15 to 30 minutes making it the most preferred choice for testing. Thus increasing awareness and the need for early detection is forcing organizations to take steps to prevent the disease thereby propeling the growth of the influenza diagnostics market in the coming years.

Advent of covid 19 and easy approval

Influenza A, B virus and covid 19 have similar symptoms in the form of respiratory illness. Covid gained dominance during the influenza season in the months of December and February. This has surged the use of influenza diagnostics kits increasing the growth of the market during the forecast period. Moreover companies are obtaining CLIA waiver approvals for test kits and tools which will help in enhancing their presence in global markets ultimately accelerating the growth of the influenza diagnostics market.

Influenza Diagnostics Market Share Analysis

Based on region, North America is expected to provide lucrative opportunities for growth in the influenza diagnostics market share during the forecast period due to growing research on diagnostic technologies for early detection of rising rising influenza cases.

Based on type, RIDTs( Rapid Influenza Diagnostic Tests) is expected to provide lucrative opportunities for growth in the influenza diagnostics market share due to their easy usage and fast results. RIDTs have also gained approval for workplace and bedside usage. It can also be used where point of care testing is required.

Based on application, the hospitals segment is expected to provide lucrative opportunities for growth in the influenza diagnostics market share. However point of care testing(POCT) will grow the fastest due to their easy use design.

Influenza Diagnostics Market Segmentation

By Type

RIDT
RT-PCR
Cell Culture
Others

By Application

Hospitals
POCT
Others

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Companies

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Scope of Influenza Diagnostics Market Report

Report Metric	Details
Report Name	Influenza Diagnostics Market
Market size value in 2020	USD 2195.6 Million
Revenue forecast in 2027	USD 3374.9 Million
Growth Rate	CAGR 6.3%
Base year considered	2020
Forecast Period	2021-2027
By Type	RIDT, RT-PCR, Cell Culture
By Application	Hospitals, POCT
Report Coverage	Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How big is the Influenza Diagnostics market?

Ans. The global Influenza Diagnostics market size is projected to reach US$ 3374.9 million by 2027, from US$ 2195.6 million in 2020, at a CAGR of 6.3% during 2021-2027.

2. Who are the major producers in the Influenza diagnostics industry?

Ans. The major producers in this industry are BD, Abbott (Include Alere) and Roche, whose combined revenue ratio in 2019 is 50.61%.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 RIDT

1.2.3 RT-PCR

1.2.4 Cell Culture

1.2.5 Others

1.3 Market by Application

1.3.1 Global Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Hospitals

1.3.3 POCT

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Influenza Diagnostics Market Perspective (2016-2027)

2.2 Influenza Diagnostics Growth Trends by Regions

2.2.1 Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Influenza Diagnostics Historic Market Share by Regions (2016-2021)

2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2022-2027)

2.3 Influenza Diagnostics Industry Dynamic

2.3.1 Influenza Diagnostics Market Trends

2.3.2 Influenza Diagnostics Market Drivers

2.3.3 Influenza Diagnostics Market Challenges

2.3.4 Influenza Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Influenza Diagnostics Players by Revenue

3.1.1 Global Top Influenza Diagnostics Players by Revenue (2016-2021)

3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2021)

3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Influenza Diagnostics Revenue

3.4 Global Influenza Diagnostics Market Concentration Ratio

3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2020

3.5 Influenza Diagnostics Key Players Head office and Area Served

3.6 Key Players Influenza Diagnostics Product Solution and Service

3.7 Date of Enter into Influenza Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Diagnostics Breakdown Data by Type

4.1 Global Influenza Diagnostics Historic Market Size by Type (2016-2021)

4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027)

5 Influenza Diagnostics Breakdown Data by Application

5.1 Global Influenza Diagnostics Historic Market Size by Application (2016-2021)

5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Influenza Diagnostics Market Size (2016-2027)

6.2 North America Influenza Diagnostics Market Size by Type

6.2.1 North America Influenza Diagnostics Market Size by Type (2016-2021)

6.2.2 North America Influenza Diagnostics Market Size by Type (2022-2027)

6.2.3 North America Influenza Diagnostics Market Size by Type (2016-2027)

6.3 North America Influenza Diagnostics Market Size by Application

6.3.1 North America Influenza Diagnostics Market Size by Application (2016-2021)

6.3.2 North America Influenza Diagnostics Market Size by Application (2022-2027)

6.3.3 North America Influenza Diagnostics Market Size by Application (2016-2027)

6.4 North America Influenza Diagnostics Market Size by Country

6.4.1 North America Influenza Diagnostics Market Size by Country (2016-2021)

6.4.2 North America Influenza Diagnostics Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Influenza Diagnostics Market Size (2016-2027)

7.2 Europe Influenza Diagnostics Market Size by Type

7.2.1 Europe Influenza Diagnostics Market Size by Type (2016-2021)

7.2.2 Europe Influenza Diagnostics Market Size by Type (2022-2027)

7.2.3 Europe Influenza Diagnostics Market Size by Type (2016-2027)

7.3 Europe Influenza Diagnostics Market Size by Application

7.3.1 Europe Influenza Diagnostics Market Size by Application (2016-2021)

7.3.2 Europe Influenza Diagnostics Market Size by Application (2022-2027)

7.3.3 Europe Influenza Diagnostics Market Size by Application (2016-2027)

7.4 Europe Influenza Diagnostics Market Size by Country

7.4.1 Europe Influenza Diagnostics Market Size by Country (2016-2021)

7.4.2 Europe Influenza Diagnostics Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Influenza Diagnostics Market Size (2016-2027)

8.2 Asia-Pacific Influenza Diagnostics Market Size by Type

8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2027)

8.3 Asia-Pacific Influenza Diagnostics Market Size by Application

8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2027)

8.4 Asia-Pacific Influenza Diagnostics Market Size by Region

8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Influenza Diagnostics Market Size (2016-2027)

9.2 Latin America Influenza Diagnostics Market Size by Type

9.2.1 Latin America Influenza Diagnostics Market Size by Type (2016-2021)

9.2.2 Latin America Influenza Diagnostics Market Size by Type (2022-2027)

9.2.3 Latin America Influenza Diagnostics Market Size by Type (2016-2027)

9.3 Latin America Influenza Diagnostics Market Size by Application

9.3.1 Latin America Influenza Diagnostics Market Size by Application (2016-2021)

9.3.2 Latin America Influenza Diagnostics Market Size by Application (2022-2027)

9.3.3 Latin America Influenza Diagnostics Market Size by Application (2016-2027)

9.4 Latin America Influenza Diagnostics Market Size by Country

9.4.1 Latin America Influenza Diagnostics Market Size by Country (2016-2021)

9.4.2 Latin America Influenza Diagnostics Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Influenza Diagnostics Market Size (2016-2027)

10.2 Middle East & Africa Influenza Diagnostics Market Size by Type

10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2027)

10.3 Middle East & Africa Influenza Diagnostics Market Size by Application

10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2027)

10.4 Middle East & Africa Influenza Diagnostics Market Size by Country

10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Details

11.1.2 BD Business Overview

11.1.3 BD Influenza Diagnostics Introduction

11.1.4 BD Revenue in Influenza Diagnostics Business (2016-2021)

11.1.5 BD Recent Development

11.2 Abbott (Include Alere)

11.2.1 Abbott (Include Alere) Company Details

11.2.2 Abbott (Include Alere) Business Overview

11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction

11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021)

11.2.5 Abbott (Include Alere) Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Influenza Diagnostics Introduction

11.3.4 Roche Revenue in Influenza Diagnostics Business (2016-2021)

11.3.5 Roche Recent Development

11.4 SIEMENS

11.4.1 SIEMENS Company Details

11.4.2 SIEMENS Business Overview

11.4.3 SIEMENS Influenza Diagnostics Introduction

11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2016-2021)

11.4.5 SIEMENS Recent Development

11.5 Analytik Jena

11.5.1 Analytik Jena Company Details

11.5.2 Analytik Jena Business Overview

11.5.3 Analytik Jena Influenza Diagnostics Introduction

11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021)

11.5.5 Analytik Jena Recent Development

11.6 Quidel

11.6.1 Quidel Company Details

11.6.2 Quidel Business Overview

11.6.3 Quidel Influenza Diagnostics Introduction

11.6.4 Quidel Revenue in Influenza Diagnostics Business (2016-2021)

11.6.5 Quidel Recent Development

11.7 Thermo Fisher

11.7.1 Thermo Fisher Company Details

11.7.2 Thermo Fisher Business Overview

11.7.3 Thermo Fisher Influenza Diagnostics Introduction

11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021)

11.7.5 Thermo Fisher Recent Development

11.8 Meridian Bioscience

11.8.1 Meridian Bioscience Company Details

11.8.2 Meridian Bioscience Business Overview

11.8.3 Meridian Bioscience Influenza Diagnostics Introduction

11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021)

11.8.5 Meridian Bioscience Recent Development

11.9 BioMerieux

11.9.1 BioMerieux Company Details

11.9.2 BioMerieux Business Overview

11.9.3 BioMerieux Influenza Diagnostics Introduction

11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2016-2021)

11.9.5 BioMerieux Recent Development

11.10 Sekisui Diagnostics

11.10.1 Sekisui Diagnostics Company Details

11.10.2 Sekisui Diagnostics Business Overview

11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction

11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021)

11.10.5 Sekisui Diagnostics Recent Development

11.11 Response Biomedical

11.11.1 Response Biomedical Company Details

11.11.2 Response Biomedical Business Overview

11.11.3 Response Biomedical Influenza Diagnostics Introduction

11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021)

11.11.5 Response Biomedical Recent Development

11.12 SA Scientific

11.12.1 SA Scientific Company Details

11.12.2 SA Scientific Business Overview

11.12.3 SA Scientific Influenza Diagnostics Introduction

11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2016-2021)

11.12.5 SA Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott (Include Alere)

List of Tables

Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of RIDT

Table 3. Key Players of RT-PCR

Table 4. Key Players of Cell Culture

Table 5. Key Players of Others

Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 7. Global Influenza Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 8. Global Influenza Diagnostics Market Size by Regions (2016-2021) & (US$ Million)

Table 9. Global Influenza Diagnostics Market Share by Regions (2016-2021)

Table 10. Global Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 11. Global Influenza Diagnostics Market Share by Regions (2022-2027)

Table 12. Influenza Diagnostics Market Trends

Table 13. Influenza Diagnostics Market Drivers

Table 14. Influenza Diagnostics Market Challenges

Table 15. Influenza Diagnostics Market Restraints

Table 16. Global Influenza Diagnostics Revenue by Players (2016-2021) & (US$ Million)

Table 17. Global Influenza Diagnostics Market Share by Players (2016-2021)

Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020)

Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2020

Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2016-2021)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Influenza Diagnostics Product Solution and Service

Table 23. Date of Enter into Influenza Diagnostics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021)

Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 29. Global Influenza Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)

Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2016-2021)

Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 33. North America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 34. North America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)

Table 35. North America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 36. North America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)

Table 37. North America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)

Table 38. North America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)

Table 39. Europe Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 40. Europe Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)

Table 41. Europe Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 42. Europe Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)

Table 43. Europe Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)

Table 44. Europe Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)

Table 45. Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 46. Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)

Table 47. Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 48. Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)

Table 49. Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021) & (US$ Million)

Table 50. Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027) & (US$ Million)

Table 51. Latin America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 52. Latin America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)

Table 53. Latin America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 54. Latin America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)

Table 55. Latin America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)

Table 56. Latin America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)

Table 57. Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 58. Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)

Table 59. Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 60. Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)

Table 61. Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)

Table 62. Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)

Table 63. BD Company Details

Table 64. BD Business Overview

Table 65. BD Influenza Diagnostics Product

Table 66. BD Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 67. BD Recent Development

Table 68. Abbott (Include Alere) Company Details

Table 69. Abbott (Include Alere) Business Overview

Table 70. Abbott (Include Alere) Influenza Diagnostics Product

Table 71. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 72. Abbott (Include Alere) Recent Development

Table 73. Roche Company Details

Table 74. Roche Business Overview

Table 75. Roche Influenza Diagnostics Product

Table 76. Roche Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 77. Roche Recent Development

Table 78. SIEMENS Company Details

Table 79. SIEMENS Business Overview

Table 80. SIEMENS Influenza Diagnostics Product

Table 81. SIEMENS Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 82. SIEMENS Recent Development

Table 83. Analytik Jena Company Details

Table 84. Analytik Jena Business Overview

Table 85. Analytik Jena Influenza Diagnostics Product

Table 86. Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 87. Analytik Jena Recent Development

Table 88. Quidel Company Details

Table 89. Quidel Business Overview

Table 90. Quidel Influenza Diagnostics Product

Table 91. Quidel Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 92. Quidel Recent Development

Table 93. Thermo Fisher Company Details

Table 94. Thermo Fisher Business Overview

Table 95. Thermo Fisher Influenza Diagnostics Product

Table 96. Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 97. Thermo Fisher Recent Development

Table 98. Meridian Bioscience Company Details

Table 99. Meridian Bioscience Business Overview

Table 100. Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 101. Meridian Bioscience Recent Development

Table 102. BioMerieux Company Details

Table 103. BioMerieux Business Overview

Table 104. BioMerieux Influenza Diagnostics Product

Table 105. BioMerieux Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 106. BioMerieux Recent Development

Table 107. Sekisui Diagnostics Company Details

Table 108. Sekisui Diagnostics Business Overview

Table 109. Sekisui Diagnostics Influenza Diagnostics Product

Table 110. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 111. Sekisui Diagnostics Recent Development

Table 112. Response Biomedical Company Details

Table 113. Response Biomedical Business Overview

Table 114. Response Biomedical Influenza Diagnostics Product

Table 115. Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 116. Response Biomedical Recent Development

Table 117. SA Scientific Company Details

Table 118. SA Scientific Business Overview

Table 119. SA Scientific Influenza Diagnostics Product

Table 120. SA Scientific Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)

Table 121. SA Scientific Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Influenza Diagnostics Market Share by Type: 2020 VS 2027

Figure 2. RIDT Features

Figure 3. RT-PCR Features

Figure 4. Cell Culture Features

Figure 5. Others Features

Figure 6. Global Influenza Diagnostics Market Share by Application: 2020 VS 2027

Figure 7. Hospitals Case Studies

Figure 8. POCT Case Studies

Figure 9. Others Case Studies

Figure 10. Influenza Diagnostics Report Years Considered

Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 12. Global Influenza Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 13. Global Influenza Diagnostics Market Share by Regions: 2020 VS 2027

Figure 14. Global Influenza Diagnostics Market Share by Regions (2022-2027)

Figure 15. Global Influenza Diagnostics Market Share by Players in 2020

Figure 16. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020

Figure 17. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2020

Figure 18. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021)

Figure 19. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027)

Figure 20. North America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 21. North America Influenza Diagnostics Market Share by Type (2016-2027)

Figure 22. North America Influenza Diagnostics Market Share by Application (2016-2027)

Figure 23. North America Influenza Diagnostics Market Share by Country (2016-2027)

Figure 24. United States Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 25. Canada Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 26. Europe Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 27. Europe Influenza Diagnostics Market Share by Type (2016-2027)

Figure 28. Europe Influenza Diagnostics Market Share by Application (2016-2027)

Figure 29. Europe Influenza Diagnostics Market Share by Country (2016-2027)

Figure 30. Germany Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. France Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. U.K. Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 33. Italy Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 34. Russia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 35. Nordic Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 36. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 37. Asia-Pacific Influenza Diagnostics Market Share by Type (2016-2027)

Figure 38. Asia-Pacific Influenza Diagnostics Market Share by Application (2016-2027)

Figure 39. Asia-Pacific Influenza Diagnostics Market Share by Region (2016-2027)

Figure 40. China Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Japan Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. South Korea Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 43. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 44. India Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 45. Australia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 46. Latin America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 47. Latin America Influenza Diagnostics Market Share by Type (2016-2027)

Figure 48. Latin America Influenza Diagnostics Market Share by Application (2016-2027)

Figure 49. Latin America Influenza Diagnostics Market Share by Country (2016-2027)

Figure 50. Mexico Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Brazil Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 52. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 53. Middle East & Africa Influenza Diagnostics Market Share by Type (2016-2027)

Figure 54. Middle East & Africa Influenza Diagnostics Market Share by Application (2016-2027)

Figure 55. Middle East & Africa Influenza Diagnostics Market Share by Country (2016-2027)

Figure 56. Turkey Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 58. UAE Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 59. BD Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 60. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 61. Roche Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 62. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 63. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 64. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 65. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 66. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 67. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 68. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 69. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 70. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Cell Culture Market

RIDT Market

COVID 19 RT PCR Test Market

Influenza A Rapid Test Kit Market

ATP Swab Test Kit Market

Medical Swab for COVID 19 Test Market

Virus Testing Diagnostic Kits Market

Digital Rapid Influenza Diagnostic Test Market

Rapid Diagnostic Testing for Influenza Market

Traditional influenza diagnostic Market

Molecular Influenza Diagnostic Market

Nasopharyngeal Swabs for COVID 19 Test Kits Market

Global Rapid Automatic Detection of Influenza Market Insights, Forecast to 2029

Global Rapid Diagnostic Testing for Influenza Market Insights, Forecast to 2029

Global Covid-19, Flu A, Flu B Antigen Detection Kit Market Research Report 2023

Global H1N1 Antigen Detection Reagent Market Research Report 2023

Global Respiratory Pathogen Detection Market Research Report 2023

Global In-Vitro Diagnostics (IVD) Devices Market Insights, Forecast to 2029

Global Viral Diagnostic Test Kits Market Research Report 2023

Global Virus Diagnostics Market Research Report 2023

Global Pallet Pooling Market Size, Status and Forecast 2021-2027

IoT Fleet Management Market Size, Share, Growth & Trends Analysis Report By Type, By Application, By Region, and Segment Forecasts, 2021-2027

Logistics Market by Mode of Transport (Railways, Airways, Roadways, and Waterways) and End Use (Healthcare, Manufacturing, Aerospace, Telecommunication, Government & Public Utilities, Banking & Financial Services, Retail, Media & Entertainment, Technology, Trade & Transportation, and Others): Global Opportunity Analysis and Industry Forecast, 2017–2027

Global Drone Logistics and Transportation Market Insights and Forecast to 2028

Global Captioning and Subtitling Solution Market Insights and Forecast to 2028

Video Analytics Market by Component (Software and Services), Deployment Mode (On-Premise and Cloud), Organization Size (Large Enterprises and Small & Medium Enterprises), Application (Retail, Critical Infrastructure, Airports, Public Transport, Police, Defense & Security, Smart Cities, Hospitality, Healthcare, BFSI, Transportation & Logistics, Manufacturing, Mining, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

Global Web Conferencing Market Insights and Forecast to 2028

Global AR and VR Lens Market Insights and Forecast to 2028

Global Cryptocurrency Hardware Wallet Market Size, Status and Forecast 2021-2027

Global SVoD Market Insights and Forecast to 2028

Global Edge Computing Market Insights and Forecast to 2028

Global Subscription and Billing Management Software Market Insights and Forecast to 2028

Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027

Published Date: June 2021

Report Code: QYRE-Auto-13Z613

Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027

FEATURED COMPANIES

Influenza Diagnostics Market

Trends Influencing the Global Influenza Diagnostics Market

Influenza Diagnostics Market Share Analysis

Influenza Diagnostics Market Segmentation

By Type

By Application

By Region

By Companies

Scope of Influenza Diagnostics Market Report

Frequently Asked Questions About This Report

1. How big is the Influenza Diagnostics market?

2. Who are the major producers in the Influenza diagnostics industry?

3. Does the report provides covid-19 impact analysis?

FEATURED COMPANIES